Domov › Nemalicelični pljučni rak › Maryland › Baltimore

Klinične študije za Nemalicelični pljučni rak v Baltimore, MD

60 študij za Nemalicelični pljučni rak išče udeležence na lokacijah v Baltimore in okolici (v razdalji približno 30 milj). Odprite študijo, da vidite, kdo lahko sodeluje in kako kontaktirati ekipo.

Uradno besedilo študije (angleško)

Iščete udeležence za študijo? Predstavite jo na vrhu te strani — $99 za 30 dni →

Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])

Vključevanje udeležencevFaza 3

Greater Baltimore Medical Center, Baltimore
Sinai Hospital of Baltimore, Baltimore
MedStar Franklin Square Medical Center/Weinberg Cancer Institute, Baltimore
in še 4

Starost 18 in več · Vsi spoli · Posodobljeno 5. okt. 2026 · NCT04267848

A Study To Assess the Safety, Tolerability, and Efficacy of Imzokitug in Combination With Pumitamig and Platinum-Doublet Chemotherapy (PDCT) Versus Pumitamig and PDCT as First-line Treatment for Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)

Vključevanje udeležencevFaza 2

Local Institution - 0123, Baltimore

Starost 18 in več · Vsi spoli · Posodobljeno 2. okt. 2026 · NCT07680764

Trial of Therapeutic Cancer Vaccine OSE2101 in Patients With Non-Small Cell Lung Cancer and Secondary Resistance to Immune Checkpoint Inhibitor

Vključevanje udeležencevFaza 3

Ascension Saint Agnes Hospital, Baltimore

Starost 18 in več · Vsi spoli · Posodobljeno 2. okt. 2026 · NCT06472245

A Platform Study in Non-Small Cell Lung Cancer (NSCLC)

Vključevanje udeležencevFaza 1/2

Research Site, Baltimore

Starost 18 in več · Vsi spoli · Posodobljeno 1. okt. 2026 · NCT06996782

Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors

Vključevanje udeležencevFaza 1

Exelixis Clinical Site #14, Baltimore

Starost 18 in več · Vsi spoli · Posodobljeno 1. okt. 2026 · NCT05176483

A Study of Investigational Agents in Participants With Previously Treated Stage IV Nonsquamous Non-small Cell Lung Cancer (NSCLC) (MK-3475-01H/KEYMAKER-U01)

Vključevanje udeležencevFaza 2

MedStar Franklin Square Medical Center ( Site 0033), Baltimore

Starost 18 in več · Vsi spoli · Posodobljeno 1. okt. 2026 · NCT06780085

A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors

Vključevanje udeležencevFaza 2

Johns Hopkins University, Baltimore

Starost 18 in več · Vsi spoli · Posodobljeno 1. okt. 2026 · NCT06172478

DK222 Study at Hopkins

Vključevanje udeležencevFaza 1

Johns Hopkins Hospital, Baltimore

Starost 18 in več · Vsi spoli · Posodobljeno 29. sep. 2026 · NCT07140315

Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)

Vključevanje udeležencevFaza 3

Johns Hopkins University of Medicine, Baltimore

Starost 18 in več · Vsi spoli · Posodobljeno 29. sep. 2026 · NCT06881784

A Study of Amivantamab in Participants With Advanced or Metastatic Solid Tumors Including Epidermal Growth Factor Receptor (EGFR)-Mutated Non-Small Cell Lung Cancer

Vključevanje udeležencevFaza 2

Sidney Kimmel Cancer Center - Bayview Campus, Baltimore

Starost 18 in več · Vsi spoli · Posodobljeno 28. sep. 2026 · NCT05498428

A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)

Vključevanje udeležencevFaza 3

Maryland Oncology Hematology, P.A., Annapolis · 22 mi stran

Starost 18 in več · Vsi spoli · Posodobljeno 28. sep. 2026 · NCT07144280

A Global Phase III Study of Rilvegostomig or Pembrolizumab Monotherapy for First-Line Treatment of PD-L1-high Metastatic Non-small Cell Lung Cancer

Vključevanje udeležencevFaza 3

Research Site, Towson · 8 mi stran

Starost 18 in več · Vsi spoli · Posodobljeno 25. sep. 2026 · NCT06868277

Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer

Vključevanje udeležencevFaza 3

Maryland Oncology Hematology, P.A., Annapolis · 22 mi stran

Starost 18 in več · Vsi spoli · Posodobljeno 25. sep. 2026 · NCT07222566

A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)

Vključevanje udeležencevFaza 2

University of Maryland, Baltimore

Starost 18 in več · Vsi spoli · Posodobljeno 25. sep. 2026 · NCT06667076

A Study to Investigate Ubamatamab With and Without Marlotamig (REGN7075) in Adult Participants With Advanced/Metastatic Non-Small Cell Lung Cancer (NSCLC)

Vključevanje udeležencevFaza 2

University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore

Starost 18 in več · Vsi spoli · Posodobljeno 25. sep. 2026 · NCT07154290

Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer

Vključevanje udeležencevFaza 3

University of Maryland, Baltimore
Johns Hopkins Bayview Medical Center, Baltimore

Starost 18 in več · Vsi spoli · Posodobljeno 24. sep. 2026 · NCT06890598

Phase III, Open-label, Study of First-line Dato-DXd in Combination With Rilvegostomig for Advanced Non-squamous NSCLC With High PD-L1 Expression (TC ≥ 50%) and Without Actionable Genomic Alterations

Vključevanje udeležencevFaza 3

Research Site, Annapolis · 22 mi stran

Starost 18 in več · Vsi spoli · Posodobljeno 23. sep. 2026 · NCT06357533

Neoadjuvant and Adjuvant Treatment in Resectable Non-small Cell Lung Cancer

Vključevanje udeležencevFaza 2

Research Site, Baltimore

Starost 18–95 · Vsi spoli · Posodobljeno 23. sep. 2026 · NCT05061550

A Study to Compare the Efficacy of Nivolumab and Relatlimab Plus Chemotherapy vs Pembrolizumab Plus Chemotherapy for Stage IV/Recurrent Non-squamous Non-small Cell Lung Cancer With PD-L1 Expression ≥ 1%

Vključevanje udeležencevFaza 3

Local Institution - 0505, Annapolis · 22 mi stran

Starost 18 in več · Vsi spoli · Posodobljeno 23. sep. 2026 · NCT06561386

A Study of Adagrasib Plus Pembrolizumab Plus Chemotherapy vs. Placebo Plus Pembrolizumab Plus Chemotherapy in Participants With Previously Untreated Non-squamous Non-small Cell Lung Cancer With KRAS G12C Mutation (KRYSTAL-4)

Vključevanje udeležencevFaza 3

Local Institution - 0702, Annapolis · 22 mi stran

Starost 18 in več · Vsi spoli · Posodobljeno 22. sep. 2026 · NCT06875310

Prospective Trial Assessing Real World Outcomes Response to Pembro in Black Patients w/ NSCLC

Vključevanje udeležencevFaza 2

University of Maryland Greenebaum Cancer Center, Baltimore
Sinai Hospital of Baltimore, Baltimore
Medstar Franklin Square, Baltimore
in še 1

Starost 18 in več · Vsi spoli · Posodobljeno 21. sep. 2026 · NCT06745882

Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients With High PD-L1

Vključevanje udeležencevFaza 3

Clinical Study Site, Baltimore

Starost 18 in več · Vsi spoli · Posodobljeno 18. sep. 2026 · NCT06767514

Study of RMC-5127 in Patients With Advanced KRAS G12V-Mutant Solid Tumors

Vključevanje udeležencevFaza 1

Johns Hopkins, Baltimore

Starost 18 in več · Vsi spoli · Posodobljeno 17. sep. 2026 · NCT07349537

A Study of [225Ac]Ac-AKY-1189 in Patients With Solid Tumors

Vključevanje udeležencevFaza 1

United Theranostics, Glen Burnie · 9 mi stran

Starost 18 in več · Vsi spoli · Posodobljeno 17. sep. 2026 · NCT07020117

Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7

Vključevanje udeležencevFaza 2/3

The Sidney Kimmel Comprehensive Cancer Center, Baltimore

Starost 18 in več · Vsi spoli · Posodobljeno 16. sep. 2026 · NCT04613596

Osimertinib Alone or With Chemotherapy for EGFR-Mutant Lung Cancers

Vključevanje udeležencevFaza 2

John Hopkins Medical Center, Baltimore

Starost 18 in več · Vsi spoli · Posodobljeno 11. sep. 2026 · NCT04410796

A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer

Vključevanje udeležencevFaza 3

Johns Hopkins Bayview Medical Center, Baltimore

Starost 18 in več · Vsi spoli · Posodobljeno 8. sep. 2026 · NCT06119581

A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer

Vključevanje udeležencevFaza 3

Saint Agnes Hospital - Baltimore - Hunt - PPDS, Baltimore

Starost 18 in več · Vsi spoli · Posodobljeno 8. sep. 2026 · NCT06793215

Phase III Study of Datopotamab Deruxtecan Versus Docetaxel in Previously Treated TROP2-positive Advanced or Metastatic Non-squamous NSCLC Without Actionable Genomic Alterations

Vključevanje udeležencevFaza 3

Research Site, Baltimore

Starost 18 in več · Vsi spoli · Posodobljeno 4. sep. 2026 · NCT07291037

Open-label Study of BBO-8520 in Adult Subjects With KRASG12C Non-small Cell Lung Cancer

Vključevanje udeležencevFaza 1

University of Maryland Marlene & Stewart Greenebaum Comprehensive Cancer Center, Baltimore

Starost 18 in več · Vsi spoli · Posodobljeno 3. sep. 2026 · NCT06343402

Blood-brain Barrier (BBB) Opening Using Exablate Focused Ultrasound With Standard of Care Treatment of NSCLC Brain Mets

Vključevanje udeležencevFaza 3

University of Maryland, Baltimore

Starost 18–100 · Vsi spoli · Posodobljeno 19. avg. 2026 · NCT05317858

A Study of Pembrolizumab With or Without Chemotherapy in Combination With Additional Treatments for Advanced Non-Small Cell Lung Cancer (NSCLC) (MK-3475-01G/KEYMAKER U01)

Vključevanje udeležencevFaza 2

MedStar Franklin Square Medical Center ( Site 0033), Baltimore

Starost 18 in več · Vsi spoli · Posodobljeno 18. avg. 2026 · NCT06731907

Testing Proton Craniospinal Radiation Therapy Versus the Usual Radiation Therapy for Leptomeningeal Metastasis, RADIATE-LM Trial

Vključevanje udeležencevFaza 3

Johns Hopkins University/Sidney Kimmel Cancer Center, Baltimore

Starost 18 in več · Vsi spoli · Posodobljeno 17. avg. 2026 · NCT06500481

Peptide Vaccine To Prevent Acquired Resistance In Patients With Advanced ALK+ NSCLC

Vključevanje udeležencevFaza 1/2

Johns Hopkins University, Baltimore

Starost 18 in več · Vsi spoli · Posodobljeno 28. jul. 2026 · NCT05950139

Clinical Trial Evaluating the Safety, Tolerability and Preliminary Efficacy of BNT116 Alone and in Combinations in Patients With Advanced Non-small Cell Lung Cancer

Vključevanje udeležencevFaza 1

Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore

Starost 18 in več · Vsi spoli · Posodobljeno 22. jul. 2026 · NCT05142189

A Study to Evaluate INCB161734 in Participants With Advanced or Metastatic Solid Tumors With KRAS G12D Mutation

Vključevanje udeležencevFaza 1

Sidney Kimmel Comprehensive Cancer Center At Johns Hopkins, Baltimore

Starost 18 in več · Vsi spoli · Posodobljeno 22. jul. 2026 · NCT06179160

A Study of SGN-CEACAM5C in Adults With Advanced Solid Tumors

Vključevanje udeležencevFaza 1

Sidney Kimmel Comprehensive Cancer at Johns Hopkins, Baltimore

Starost 18 in več · Vsi spoli · Posodobljeno 22. jul. 2026 · NCT06131840

Study of STK-012 Alone and With Other Treatments in Patients With Advanced Lung Cancer and Other Cancers

Vključevanje udeležencevFaza 1/2

University of Maryland, Baltimore

Starost 18 in več · Vsi spoli · Posodobljeno 21. jul. 2026 · NCT05098132

A Study of Novel Combinations in Non-Small Cell Lung Cancer (NSCLC)

Vključevanje udeležencevFaza 2

Research Site, Baltimore

Starost 18 in več · Vsi spoli · Posodobljeno 1. jul. 2026 · NCT07098338

GCC 2546- Motion Management

Vključevanje udeležencev

University of Maryland Greenebaum Cancer Center, Baltimore

Starost 18 in več · Vsi spoli · Posodobljeno 26. jun. 2026 · NCT07398209

Safety and Tolerability of ²¹²Pb-DOTAM-GRPR1 in Adult Subjects With Recurrent or Metastatic GRPR-expressing Tumors

Vključevanje udeležencevFaza 1

Advanced Molecular Imaging and Therapy, Glen Burnie · 9 mi stran
United Theranostics - Chesapeake, Glen Burnie · 9 mi stran

Starost 18 in več · Vsi spoli · Posodobljeno 11. jun. 2026 · NCT05283330

Study With ABBV-CLS-484 in Participants With Locally Advanced or Metastatic Tumors

Vključevanje udeležencevFaza 1

Johns Hopkins Hospital /ID# 254056, Baltimore

Starost 18 in več · Vsi spoli · Posodobljeno 4. jun. 2026 · NCT04777994

Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)

Vključevanje udeležencevFaza 2

Kaiser Permanente-Woodlawn Medical Center, Baltimore
Kaiser Permanente Lutherville - Timonium Medical Center, Lutherville · 9 mi stran

Starost 18 in več · Vsi spoli · Posodobljeno 3. jun. 2026 · NCT05642572

Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors

Vključevanje udeležencevFaza 1

Johns Hopkins University, Baltimore

Starost 18 in več · Vsi spoli · Posodobljeno 3. jun. 2026 · NCT06040541

A Study to Evaluate the Safety, Tolerability, and Efficacy of BMS-986523 Alone and in Combination With Anti-Cancer Agents in Participants With Advanced Solid Malignancies

Vključevanje udeležencevFaza 1/2

Johns Hopkins Hospital, Baltimore

Starost 18 in več · Vsi spoli · Posodobljeno 28. maj 2026 · NCT07223047

Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS

Vključevanje udeležencevFaza 1/2

Johns Hopkins University, Baltimore

Starost 18 in več · Vsi spoli · Posodobljeno 15. maj 2026 · NCT05379985

A Study to Investigate the Efficacy and Safety of Dato-DXd With or Without Osimertinib Compared With Platinum Based Doublet Chemotherapy in Participants With EGFR-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer

Vključevanje udeležencevFaza 3

Research Site, Baltimore

Starost 18–130 · Vsi spoli · Posodobljeno 14. maj 2026 · NCT06417814

A Study Evaluating Neoadjuvant Chemoimmunotherapy With Immunosensitizing Radiation for Borderline Resectable Non-Small Cell Lung Cancer

Vključevanje udeležencevFaza 1

Maryland Proton Treatment Center, Baltimore
University of Maryland Greenebaum Cancer Center, Baltimore
Baltimore Washington Medical Center- Tate Cancer Center, Glen Burnie · 9 mi stran
in še 1

Starost 18 in več · Vsi spoli · Posodobljeno 6. maj 2026 · NCT06800339

Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)

Vključevanje udeležencevFaza 2/3

Saint Agnes Hospital, Baltimore
Kaiser Permanente-Woodlawn Medical Center, Baltimore
Kaiser Permanente Lutherville - Timonium Medical Center, Lutherville · 9 mi stran

Starost 18 in več · Vsi spoli · Posodobljeno 5. maj 2026 · NCT06616584